Lonza | LONN - Operating Profit

Stock Price
488.30
Daily Change
6.00 1.24%
Monthly
-8.39%
Yearly
-13.42%
Q1 Forecast
468.93

Lonza reported CHF430M in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 313M 19M Dec/2025
Almirall EUR 30.23M 12.8M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
BASF EUR -175M 668M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
Beiersdorf EUR 504M 312M Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Demant DKK 2.09B 224M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Geberit CHF 199.9M 4.4M Sep/2025
Genmab DKK 360M 172M Jun/2025
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GN Store Nord DKK 570M 230M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Johnson Matthey GBP 142M 89M Dec/2025
Merck EUR 474M 738M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sika AG CHF 798.1M 93.6M Jun/2025
Smith & Nephew USD 440M 50M Dec/2025
Solvay EUR 60M 78M Dec/2025
UCB EUR 1B 678M Dec/2024